Dexcom Inc <DXCM.O>: Truist Securities raises target price to $102 from $93
DXCM•Related News
Sandoz Canada wins Health Canada approval for generic Ozempic semaglutide
NVS•
Salesforce.com, Inc. <CRM.N>: Wells Fargo Raises Target Price to $250 From $230
CRM•
India finds Nestle baby food sample substandard, takes legal action
XLP•
Pentair appoints ex-Regal Rexnord CEO Louis Pinkham to board, names him to audit and finance committee
PNR•
Lennar Corp. cuts target price to $70 from $79
LEN•